Therapeutics: Free fatty acid receptor 2 (FFAR2; GPR43); FFAR3 (GPR41)

Endocrine/metabolic disease

INDICATION: Diabetes

Cell culture and mouse studies suggest FFAR2 and FFAR3 antagonists

Read the full 129 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE